Learn about the impact of Alzheimer's family history on brain resilience and memory function. Your family tree may shape your ...

Claire Day, the Chief Mission and Program Strategy Officer for the Alzheimer's Association of Northern California & Northern ...

Music therapy is proving to be a powerful adjunct treatment for a range of conditions, including Alzheimer’s disease, chronic ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

A novel artificial intelligence (AI) tool has revealed how disease-linked proteins misfold into harmful structures, a key ...

Father With Alzheimer's? You May Be More at Risk of Brain Changes Apr. 9, 2025 — While some studies have suggested that having a mother with Alzheimer's disease may put you more at risk of ...

Both GLP-1 receptor agonists and SGLT2 inhibitors linked to reduced risk for ADRD, with no significant difference between them.

A novel artificial intelligence (AI) tool has revealed how disease-linked proteins misfold into harmful structures, a key ...

Randall Bateman, MD, Charles F and Joanne Knight Distinguished Professor of Neurology at WashU Medicine. A study of Roche's anti-amyloid drug gantenerumab has suggested that early treatment to ...

The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China, and Japan gave a green light to ...